» Articles » PMID: 34375170

Outcomes of Patients Denied Extracorporeal Membrane Oxygenation During the COVID-19 Pandemic in Greater Paris, France

Overview
Specialty Critical Care
Date 2021 Aug 10
PMID 34375170
Citations 12
Authors
Affiliations
Soon will be listed here.
Citing Articles

Outcomes and risk factors of transported patients with extracorporeal membrane oxygenation: An ECMO center experience.

Liu L, Hu D, Hao T, Chen S, Chen L, Zhu Y J Intensive Med. 2025; 5(1):35-42.

PMID: 39872835 PMC: 11763234. DOI: 10.1016/j.jointm.2024.04.003.


Lung Transplant Success in COVID-19 Patients Requiring V-V ECMO: One-Year Follow-Up.

Odish M, Pollema T, Lin C, Owens R, Yi C, LeBlanc S Ann Transplant. 2024; 29:e946088.

PMID: 39716460 PMC: 11684344. DOI: 10.12659/AOT.946088.


Extracorporeal membrane oxygenation: unmet needs and perspectives.

Permenov B, Zimba O, Yessirkepov M, Anartayeva M, Suigenbayev D, Kocyigit B Rheumatol Int. 2024; 44(12):2745-2756.

PMID: 39412573 DOI: 10.1007/s00296-024-05732-z.


Use of Extracorporeal Membrane Oxygenation for Patients with Coronavirus Disease 2019 Infection.

Ruck J, Bush E Adv Surg. 2024; 58(1):249-273.

PMID: 39089781 PMC: 11294677. DOI: 10.1016/j.yasu.2024.05.003.


Outcomes of Severe ARDS COVID-19 Patients Denied for Venovenous ECMO Support: A Prospective Observational Comparative Study.

Sylvestre A, Forel J, Textoris L, Gragueb-Chatti I, Daviet F, Salmi S J Clin Med. 2024; 13(5).

PMID: 38592410 PMC: 10932228. DOI: 10.3390/jcm13051493.


References
1.
Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

2.
Lebreton G, Schmidt M, Ponnaiah M, Folliguet T, Para M, Guihaire J . Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study. Lancet Respir Med. 2021; 9(8):851-862. PMC: 8055207. DOI: 10.1016/S2213-2600(21)00096-5. View

3.
Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M . Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Lancet Respir Med. 2020; 8(5):518-526. PMC: 7102637. DOI: 10.1016/S2213-2600(20)30121-1. View

4.
Schmidt M, Hajage D, Lebreton G, Monsel A, Voiriot G, Levy D . Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study. Lancet Respir Med. 2020; 8(11):1121-1131. PMC: 7426089. DOI: 10.1016/S2213-2600(20)30328-3. View

5.
Beigel J, Tomashek K, Dodd L, Mehta A, Zingman B, Kalil A . Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med. 2020; 383(19):1813-1826. PMC: 7262788. DOI: 10.1056/NEJMoa2007764. View